Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essential thrombocythemia

British Journal of Haematology

Volumn 126, Issue 6, 2004, Pages 885-886

  Cacciola, Rossella R ^a   Di Francesco, Ernesto ^a   Giustolisi, Rosario ^a   Cacciola, Emma ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Anagrelide; Essential thrombocythaemia; Platelet factor 4; Vascular endothelial growth factor

Indexed keywords

ACETYLSALICYLIC ACID; ALKYLATING AGENT; ALPHA INTERFERON; ANAGRELIDE; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; HYDROXYUREA; INDOBUFEN; THROMBOCYTE FACTOR 4; VASCULOTROPIN;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTHEMIA;

ADULT; BLOOD PLATELETS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET FACTOR 4; QUINAZOLINES; THROMBOCYTHEMIA, HEMORRHAGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4644233697     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05139.x     Document Type: Letter

References (6)

1. Bellucci, S., Ignatova, E., Jaillet, N. & Boffa, M.C. (1993) Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF. Thrombosis and Haemostasis, 70, 736-742.
2. Laguna, M.S., Kornblihtt, L.I., Marta, R.F. & Molinas, F.C. (2000a) Thromboxane B2 and platelet derived growth factor in essential thrombocythemia treated with anagrelide. Medicina (B Aires), 60, 448-452.
3. Laguna, M.S., Kornblihtt, L.I., Marta, R.F., Michiels, J.J. & Molinas, F.C. (2000b) Effectiveness of anagrelide in the treatment of symptomatic patients with essential thrombocythemia. Clinical and Applied Thrombosis/Hemostasis, 6, 157-161.
4. Mesa, R.A., Hanson, C.A., Rajkumar, V.S., Schroeder, G. & Tefferi, A. (2000) Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood, 96, 3374-3380.
5. Spivak, J.L., Barosi, G., Tognoni, G., Barbui, T., Finazzi, G., Marchioli R. & Marchetti, M. (2003) Chronic myeloproliferative disorders. Hematology, 200-224.
6. Thiele, J., Kvasnicka, H.M., Fuchs, N., Brunnbauer, K., Volkwein, N. & Schmitt-Graeff, A. (2003) Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. An immunohistochemical and morphometric study of sequential trephine biopsies. Haematologica, 88, 1130-1138.